Achieving definitive results in long-chain polyunsaturated fatty acid supplementation trials of term infants: factors for consideration
- 1 April 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 69 (4) , 205-214
Abstract
Numerous randomized controlled trials (RCTs) have been undertaken to determine whether supplementation with long-chain polyunsaturated fatty acids (LCPUFAs) in infancy would improve the developmental outcomes of term infants. The results of such trials have been thoroughly reviewed with no definitive conclusion as to the efficacy of LCPUFA supplementation. A number of reasons for the lack of conclusive findings in this area have been proposed. This review examines such factors with the aim of determining whether an optimal method of investigation for RCTs of LCPUFA supplementation in term infants can be ascertained from previous research. While more research is required to completely inform a method that is likely to achieve definitive results, the findings of this literature review indicate future trials should investigate the effects of sex, genetic polymorphisms, the specific effects of LCPUFAs, and the optimal tests for neurodevelopmental assessment. The current literature indicates a docosahexaenoic acid dose of 0.32%, supplementation from birth to 12 months, and a total sample size of at least 286 (143 per group) should be included in the methodology of future trials.Keywords
This publication has 83 references indexed in Scilit:
- Outcomes for Mothers and Their Babies: Do n-3 Long-Chain Polyunsaturated Fatty Acids and Seafoods Make a Difference?Journal of the American Dietetic Association, 2008
- Dietary (n-3) Fatty Acids and Brain Development1The Journal of Nutrition, 2007
- Polyunsaturated Fatty Acids in Human Milk2004
- Exclusive Breastfeeding of Healthy Term Infants for at Least 6 Weeks Improves Neurological ConditionThe Journal of Nutrition, 2003
- Mechanisms of action of docosahexaenoic acid in the nervous systemLipids, 2001
- Infant plasma trans , n−6, and n−3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and lengthThe American Journal of Clinical Nutrition, 2001
- Long Chain Polyunsaturated Fatty Acid Formation in Neonates: Effect of Gestational Age and Intrauterine GrowthPediatric Research, 2000
- Tissue levels of polyunsaturated fatty acids during early human developmentThe Journal of Pediatrics, 1992
- Omega-3 fatty acids in health and disease and in growth and developmentThe American Journal of Clinical Nutrition, 1991
- Lipids of nervous tissue: Composition and metabolismProgress in Lipid Research, 1985